State Policy · IN
Indiana Medicaid to Cover GLP-1 Medications for Obesity Under Federal Initiative
Indiana Governor Mike Braun directed the state's Family and Social Services Administration to cover GLP-1 medications for obesity through a federal Centers for Medicare & Medicaid Innovation Center initiative. The policy will affect 1.9 million Medicaid enrollees in Indiana. The directive was issued July 30, 2026, though specific implementation timelines were not provided in the announcement. This marks a significant expansion of pharmacy benefits for Indiana's Medicaid population, as most state Medicaid programs have historically excluded coverage of anti-obesity medications.
Why it mattersThis state-level policy change will trigger significant pharmacy cost implications for Indiana's managed care plans and require immediate formulary updates, prior authorization protocol development, and medical management strategies for GLP-1 utilization.
Also covered by:indianacapitalchronicle.com